|
1
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
Burden of Disease Study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muto Y, Chochi K, Morita D, Oka A and
Rikiyama T: An elderly patient with metastatic colon cancer
achieved long-term survival following single-agent chemotherapy
with S-1. Gan To Kagaku Ryoho. 45:55–57. 2018.(In Japanese).
PubMed/NCBI
|
|
5
|
Sun LY: Essential and interpretation of
Japanese society for cancer of the colon and rectum (JSCCR)
guidelines 2019 for the treatment of colorectal cancer. Zhonghua
Wei Chang Wai Ke Za Zhi. 22:1088–1094. 2019.(In Chinese).
PubMed/NCBI
|
|
6
|
Taieb J, Shi Q, Pederson L, Alberts S,
Wolmark N, Van Cutsem E, de Gramont A, Kerr R, Grothey A, Lonardi
S, et al: Prognosis of microsatellite instability and/or mismatch
repair deficiency stage III colon cancer patients after disease
recurrence following adjuvant treatment: Results of an ACCENT
pooled analysis of seven studies. Ann Oncol. 30:1466–1471. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Connell JB, Maggard MA and Ko CY: Colon
cancer survival rates with the new American joint committee on
cancer sixth edition staging. J Natl Cancer Inst. 96:1420–1425.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fang WG and Tian XX: Identification of a
new pro-invasion factor in tumor microenvironment: Progress in
function and mechanism of extracellular ATP. Beijing Da Xue Xue Bao
Yi Xue Ban. 49:188–195. 2017.(In Chinese). PubMed/NCBI
|
|
9
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: TGF-β-induced upregulation of malat1 promotes bladder
cancer metastasis by associating with suz12. Clin Cancer Res.
20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao Y, Guo Q, Chen J, Hu J, Wang S and
Sun Y: Role of long non-coding RNA HULC in cell proliferation,
apoptosis and tumor metastasis of gastric cancer: A clinical and in
vitro investigation. Oncol Rep. 31:358–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diepenbruck M and Christofori G:
Epithelial-mesenchymal transition (EMT) and metastasis: Yes, no,
maybe? Curr Opin Cell Biol. 43:7–13. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lou Y, Diao L, Cuentas ER, Denning WL,
Chen L, Fan YH, Byers LA, Wang J, Papadimitrakopoulou VA, Behrens
C, et al: Epithelial-mesenchymal transition is associated with a
distinct tumor microenvironment including elevation of inflammatory
signals and multiple immune checkpoints in lung adenocarcinoma.
Clin Cancer Res. 22:3630–3642. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tan TZ, Miow QH, Miki Y, Noda T, Mori S,
Huang RY and Thiery JP: Epithelial-mesenchymal transition spectrum
quantification and its efficacy in deciphering survival and drug
responses of cancer patients. EMBO Mol Med. 6:1279–1293. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu BB, Wang H, Chi YF, Wang YM, Yao XM,
Liu S, Qiu H, Fang J, Yin PH, Zhang XM and Peng W: Protective
effects of probucol on Ox-LDL-induced epithelial-mesenchymal
transition in human renal proximal tubular epithelial cells via
LOX1/ROS/MAPK signaling. Mol Med Rep. 17:1289–1296. 2018.PubMed/NCBI
|
|
15
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma S, Deng X, Yang Y, Zhang Q, Zhou T and
Liu Z: The lncRNA LINC00675 regulates cell proliferation,
migration, and invasion by affecting Wnt/β-catenin signaling in
cervical cancer. Biomed Pharmacother. 108:1686–1693. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bentwich I, Avniel A, Karov Y, Aharonov R,
Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, et al:
Identification of hundreds of conserved and nonconserved human
microRNAs. Nat Genet. 37:766–770. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berezikov E, Guryev V, van de Belt J,
Wienholds E, Plasterk RH and Cuppen E: Phylogenetic shadowing and
computational identification of human microRNA genes. Cell.
120:21–24. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stojkovic S, Jurisic M, Kopp CW,
Koppensteiner R, Huber K, Wojta J and Gremmel T: Circulating
microRNAs identify patients at increased risk of in-stent
restenosis after peripheral angioplasty with stent implantation.
Atherosclerosis. 269:197–203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lim LP, Glasner ME, Yekta S, Burge CB and
Bartel DP: Vertebrate microRNA genes. Science. 299:15402003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang G, Hou X, Li Y and Zhao M: MiR-205
inhibits cell apoptosis by targeting phosphatase and tensin homolog
deleted on chromosome ten in endometrial cancer Ishikawa cells. BMC
Cancer. 14:4402014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lebanony D, Benjamin H, Gilad S, Ezagouri
M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H, et
al: Diagnostic assay based on hsa-miR-205 expression distinguishes
squamous from nonsquamous non-small-cell lung carcinoma. J Clin
Oncol. 27:2030–2037. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qin AY, Zhang XW, Liu L, Yu JP, Li H, Wang
SZ, Ren XB and Cao S: MiR-205 in cancer: An angel or a devil? Eur J
Cell Biol. 92:54–60. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grelet S, Link LA, Howley B, Obellianne C,
Palanisamy V, Gangaraju VK, Diehl JA and Howe PH: A regulated PNUTS
mRNA to lncRNA splice switch mediates EMT and tumour progression.
Nat Cell Biol. 19:1105–1115. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tellez CS, Juri DE, Do K, Bernauer AM,
Thomas CL, Damiani LA, Tessema M, Leng S and Belinsky SA: EMT and
stem cell-like properties associated with miR-205 and miR-200
epigenetic silencing are early manifestations during
carcinogen-induced transformation of human lung epithelial cells.
Cancer Res. 71:3087–3097. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vosgha H, Ariana A, Smith RA and Lam AK:
miR-205 targets angiogenesis and EMT concurrently in anaplastic
thyroid carcinoma. Endocr Relat Cancer. 25:323–337. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shvarts A, Steegenga WT, Riteco N, van
Laar T, Dekker P, Bazuine M, van Ham RC, van der Houven van Oordt
W, Hateboer G, van der Eb AJ and Jochemsen AG: MDMX: A novel
p53-binding protein with some functional properties of MDM2. EMBO
J. 15:5349–5357. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Golestanian S, Sharifi A, Popowicz GM,
Azizian H, Foroumadi A, Szwagierczak A, Holak TA and Amanlou M:
Discovery of novel dual inhibitors against Mdm2 and Mdmx proteins
by in silico approaches and binding assay. Life Sci. 145:240–246.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Popowicz GM, Czarna A and Holak TA:
Structure of the human Mdmx protein bound to the p53 tumor
suppressor transactivation domain. Cell Cycle. 7:2441–2443. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gansmo LB, Romundstad P, Birkeland E,
Hveem K, Vatten L, Knappskog S and Lonning PE: MDM4 SNP34091
(rs4245739) and its effect on breast-, colon-, lung-, and prostate
cancer risk. Cancer Med. 4:1901–1907. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu L, Zhang H, Bergholz J, Sun S and Xiao
ZX: MDM2/MDMX: Master negative regulators for p53 and RB. Mol Cell
Oncol. 3:e11066352016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pedram N, Pouladi N, Feizi MA, Montazeri
V, Sakhinia E and Estiar MA: Analysis of the association between
MDM4 rs4245739 single nucleotide polymorphism and breast cancer
susceptibility. Clin Lab. 62:1303–1308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Siebring-van Olst E, Blijlevens M, de
Menezes RX, van der Meulen-Muileman IH, Smit EF and van Beusechem
VW: A genome-wide siRNA screen for regulators of tumor suppressor
p53 activity in human non-small cell lung cancer cells identifies
components of the RNA splicing machinery as targets for anticancer
treatment. Mol Oncol. 11:534–551. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:2015. View Article : Google Scholar
|
|
36
|
Chee SMQ, Wongsantichon J, Siau J, Thean
D, Ferrer F, Robinson RC, Lane DP, Brown CJ and Ghadessy FJ:
Structure-activity studies of Mdm2/Mdm4-binding stapled peptides
comprising non-natural amino acids. PLoS One. 12:e01893792017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu Z, Zhang H, Tao Y, Li X and Li G: MDM4
genetic variants predict HPV16-positive tumors of patients with
squamous cell carcinoma of the oropharynx. Oncotarget.
8:86710–86717. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ten Kate FJ, Suzuki L, Dorssers LC,
Dinjens WN, Jones DT, Nieboer D, Doukas M, Van Lanschot JJ,
Wijnhoven BP, Looijenga LH and Biermann K: Pattern of p53 protein
expression is predictive for survival in chemoradiotherapy-naive
esophageal adenocarcinoma. Oncotarget. 8:104123–104135. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gilkes DM, Pan Y, Coppola D, Yeatman T,
Reuther GW and Chen J: Regulation of MDMX expression by mitogenic
signaling. Mol Cell Biol. 28:1999–2010. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McCubrey JA, Lertpiriyapong K, Fitzgerald
TL, Martelli AM, Cocco L, Rakus D, Gizak A, Libra M, Cervello M,
Montalto G, et al: Roles of TP53 in determining therapeutic
sensitivity, growth, cellular senescence, invasion and metastasis.
Adv Biol Regul. 63:32–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang K, Sun F, Zhu J, Luo G, Ban Y and
Zhang P: miR-33a inhibits cell growth in renal cancer by
downregulation of MDM4 expression. Mol Genet Genomic Med.
7:e8332019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen W, Cai G, Liao Z, Lin K, Li G and Li
Y: miRNA-766 induces apoptosis of human colon cancer cells through
the p53/Bax signaling pathway by MDM4. Exp Ther Med. 17:4100–4108.
2019.PubMed/NCBI
|
|
43
|
Gulei D, Magdo L, Jurj A, Raduly L,
Cojocneanu-Petric R, Moldovan A, Moldovan C, Florea A, Pasca S, Pop
LA, et al: The silent healer: miR-205-5p up-regulation inhibits
epithelial to mesenchymal transition in colon cancer cells by
indirectly up-regulating E-cadherin expression. Cell Death Dis.
9:662018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nguyen-Vu T, Wang J, Mesmar F,
Mukhopadhyay S, Saxena A, McCollum CW, Gustafsson JÅ, Bondesson M
and Williams C: Estrogen receptor beta reduces colon cancer
metastasis through a novel miR-205-PROX1 mechanism. Oncotarget.
7:42159–42171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yamada Y, Nishikawa R, Kato M, Okato A,
Arai T, Kojima S, Yamazaki K, Naya Y, Ichikawa T and Seki N:
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell
aggressiveness and is involved in prostate cancer pathogenesis. J
Hum Genet. 63:195–205. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Braicu OL, Budisan L, Buiga R, Jurj A,
Achimas-Cadariu P, Pop LA, Braicu C, Irimie A and Berindan-Neagoe
I: miRNA expression profiling in formalin-fixed paraffin-embedded
endometriosis and ovarian cancer samples. Onco Targets Ther.
10:4225–4238. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li JH, Sun SS, Li N, Lv P, Xie SY and Wang
PY: MiR-205 as a promising biomarker in the diagnosis and prognosis
of lung cancer. Oncotarget. 8:91938–91949. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wei J, Zhang L, Li J, Zhu S, Tai M, Mason
CW, Chapman JA, Reynolds EA, Weiner CP and Zhou HH: MicroRNA-205
promotes cell invasion by repressing TCF21 in human ovarian cancer.
J Ovarian Res. 10:332017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu CG, Yang MF, Fan JX and Wang W: MiR-30a
and miR-205 are downregulated in hypoxia and modulate
radiosensitivity of prostate cancer cells by inhibiting autophagy
via TP53INP1. Eur Rev Med Pharmacol Sci. 20:1501–1508.
2016.PubMed/NCBI
|
|
50
|
Yang G, Zhang P, Lv A, Liu Y and Wang G:
MiR-205 functions as a tumor suppressor via targeting TGF-α in
osteosarcoma. Exp Mol Pathol. 100:160–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhuang L, Guo J, Yao Y and Li Z: miR-205
targets runt-related transcription factor 2 to inhibit human
pancreatic cancer progression. Oncol Lett. 17:843–848.
2019.PubMed/NCBI
|
|
52
|
Chen S, Jin L, Nie S, Han L, Lu N and Zhou
Y: MiR-205 inhibits growth and invasion of neuroblastoma by
targeting cAMP responsive element binding protein 1. Oncol Res.
26:445–455. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Xu C, Li M, Zhang L, Bi Y, Wang P, Li J
and Jiang X: MicroRNA-205 suppresses the invasion and
epithelial-mesenchymal transition of human gastric cancer cells.
Mol Med Rep. 13:4767–4773. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pang H and Yue X: MiR-205 serves as a
prognostic factor and suppresses proliferation and invasion by
targeting insulin-like growth factor receptor 1 in human cervical
cancer. Tumour Biol. 39:10104283177013082017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yin WZ, Li F, Zhang L, Ren XP, Zhang N and
Wen JF: Down-regulation of microRNA-205 promotes gastric cancer
cell proliferation. Eur Rev Med Pharmacol Sci. 18:1027–1032.
2014.PubMed/NCBI
|
|
56
|
Chen T, You Y, Jiang H and Wang ZZ:
Epithelial-mesenchymal transition (EMT): A biological process in
the development, stem cell differentiation, and tumorigenesis. J
Cell Physiol. 232:3261–3272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Rodriguez-Monterrosas C, Diaz-Aragon R,
Leal-Orta E, Cortes-Reynosa P and Perez Salazar E: Insulin induces
an EMT-like process in mammary epithelial cells MCF10A. J Cell
Biochem. 119:4061–4071. 2018. View Article : Google Scholar : PubMed/NCBI
|
